nodes	percent_of_prediction	percent_of_DWPC	metapath
Vecuronium—ABCB1—Dactinomycin—sarcoma	0.173	0.289	CbGbCtD
Vecuronium—ABCB1—Mitoxantrone—sarcoma	0.154	0.259	CbGbCtD
Vecuronium—ABCB1—Vincristine—sarcoma	0.106	0.178	CbGbCtD
Vecuronium—ABCB1—Etoposide—sarcoma	0.0974	0.163	CbGbCtD
Vecuronium—CHRND—pericardium—sarcoma	0.0774	0.473	CbGeAlD
Vecuronium—ABCB1—Doxorubicin—sarcoma	0.0664	0.111	CbGbCtD
Vecuronium—Muscle atrophy—Vincristine—sarcoma	0.0236	0.0987	CcSEcCtD
Vecuronium—CHRNA2—mammary gland—sarcoma	0.0153	0.0937	CbGeAlD
Vecuronium—CHRNA1—hematopoietic system—sarcoma	0.0112	0.0688	CbGeAlD
Vecuronium—CHRND—tendon—sarcoma	0.00892	0.0546	CbGeAlD
Vecuronium—Paralysis—Vincristine—sarcoma	0.00802	0.0335	CcSEcCtD
Vecuronium—CHRNA1—lymphoid tissue—sarcoma	0.00792	0.0485	CbGeAlD
Vecuronium—Injection site pain—Thiotepa—sarcoma	0.0077	0.0321	CcSEcCtD
Vecuronium—CHRNA1—tendon—sarcoma	0.00744	0.0455	CbGeAlD
Vecuronium—CHRNB1—tendon—sarcoma	0.00575	0.0352	CbGeAlD
Vecuronium—Respiratory failure—Vincristine—sarcoma	0.00567	0.0237	CcSEcCtD
Vecuronium—Apnoea—Etoposide—sarcoma	0.00532	0.0222	CcSEcCtD
Vecuronium—CHRNB1—testis—sarcoma	0.00476	0.0291	CbGeAlD
Vecuronium—CHRNB1—liver—sarcoma	0.0045	0.0275	CbGeAlD
Vecuronium—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00407	0.017	CcSEcCtD
Vecuronium—Redness—Epirubicin—sarcoma	0.00375	0.0156	CcSEcCtD
Vecuronium—Paralysis—Epirubicin—sarcoma	0.00364	0.0152	CcSEcCtD
Vecuronium—Muscular weakness—Vincristine—sarcoma	0.00357	0.0149	CcSEcCtD
Vecuronium—Redness—Doxorubicin—sarcoma	0.00347	0.0145	CcSEcCtD
Vecuronium—CHRNB1—lymph node—sarcoma	0.00345	0.0211	CbGeAlD
Vecuronium—Anaphylactoid reaction—Etoposide—sarcoma	0.00339	0.0141	CcSEcCtD
Vecuronium—Paralysis—Doxorubicin—sarcoma	0.00337	0.0141	CcSEcCtD
Vecuronium—Rash erythematous—Epirubicin—sarcoma	0.0033	0.0138	CcSEcCtD
Vecuronium—Connective tissue disorder—Thiotepa—sarcoma	0.0031	0.0129	CcSEcCtD
Vecuronium—Injection site pain—Epirubicin—sarcoma	0.0031	0.0129	CcSEcCtD
Vecuronium—Rash erythematous—Doxorubicin—sarcoma	0.00306	0.0128	CcSEcCtD
Vecuronium—Cardiac disorder—Thiotepa—sarcoma	0.00293	0.0122	CcSEcCtD
Vecuronium—Flushing—Dactinomycin—sarcoma	0.00291	0.0121	CcSEcCtD
Vecuronium—Injection site pain—Doxorubicin—sarcoma	0.00287	0.012	CcSEcCtD
Vecuronium—Angiopathy—Thiotepa—sarcoma	0.00286	0.0119	CcSEcCtD
Vecuronium—Immune system disorder—Thiotepa—sarcoma	0.00285	0.0119	CcSEcCtD
Vecuronium—Mediastinal disorder—Thiotepa—sarcoma	0.00284	0.0119	CcSEcCtD
Vecuronium—SLC22A1—liver—sarcoma	0.00283	0.0173	CbGeAlD
Vecuronium—Bronchospasm—Etoposide—sarcoma	0.00279	0.0116	CcSEcCtD
Vecuronium—Connective tissue disorder—Vincristine—sarcoma	0.00275	0.0115	CcSEcCtD
Vecuronium—Erythema—Thiotepa—sarcoma	0.00275	0.0115	CcSEcCtD
Vecuronium—Erythema—Dactinomycin—sarcoma	0.00273	0.0114	CcSEcCtD
Vecuronium—Cardiac disorder—Vincristine—sarcoma	0.0026	0.0108	CcSEcCtD
Vecuronium—Angiopathy—Vincristine—sarcoma	0.00254	0.0106	CcSEcCtD
Vecuronium—Mediastinal disorder—Vincristine—sarcoma	0.00252	0.0105	CcSEcCtD
Vecuronium—Injection site reaction—Epirubicin—sarcoma	0.00252	0.0105	CcSEcCtD
Vecuronium—Erythema—Mitoxantrone—sarcoma	0.00237	0.0099	CcSEcCtD
Vecuronium—Injection site reaction—Doxorubicin—sarcoma	0.00233	0.00971	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00232	0.00969	CcSEcCtD
Vecuronium—Nervous system disorder—Thiotepa—sarcoma	0.0022	0.00918	CcSEcCtD
Vecuronium—Tachycardia—Thiotepa—sarcoma	0.00219	0.00913	CcSEcCtD
Vecuronium—Skin disorder—Thiotepa—sarcoma	0.00218	0.00909	CcSEcCtD
Vecuronium—Flushing—Etoposide—sarcoma	0.0021	0.00878	CcSEcCtD
Vecuronium—Cardiac disorder—Etoposide—sarcoma	0.0021	0.00878	CcSEcCtD
Vecuronium—Angiopathy—Etoposide—sarcoma	0.00206	0.00858	CcSEcCtD
Vecuronium—ABCB1—myometrium—sarcoma	0.00205	0.0126	CbGeAlD
Vecuronium—Immune system disorder—Etoposide—sarcoma	0.00205	0.00855	CcSEcCtD
Vecuronium—Mediastinal disorder—Etoposide—sarcoma	0.00204	0.00853	CcSEcCtD
Vecuronium—Anaphylactic shock—Vincristine—sarcoma	0.00199	0.0083	CcSEcCtD
Vecuronium—ABCB1—embryo—sarcoma	0.00198	0.0121	CbGeAlD
Vecuronium—Nervous system disorder—Vincristine—sarcoma	0.00195	0.00814	CcSEcCtD
Vecuronium—Anaphylactic shock—Mitoxantrone—sarcoma	0.00194	0.00808	CcSEcCtD
Vecuronium—Shock—Mitoxantrone—sarcoma	0.0019	0.00795	CcSEcCtD
Vecuronium—Anaphylactoid reaction—Epirubicin—sarcoma	0.0019	0.00792	CcSEcCtD
Vecuronium—Tachycardia—Mitoxantrone—sarcoma	0.00189	0.00789	CcSEcCtD
Vecuronium—Skin disorder—Mitoxantrone—sarcoma	0.00188	0.00785	CcSEcCtD
Vecuronium—Hypotension—Vincristine—sarcoma	0.00186	0.00775	CcSEcCtD
Vecuronium—ABCB1—seminal vesicle—sarcoma	0.00186	0.0114	CbGeAlD
Vecuronium—Hypotension—Mitoxantrone—sarcoma	0.00181	0.00755	CcSEcCtD
Vecuronium—Urticaria—Thiotepa—sarcoma	0.00178	0.00743	CcSEcCtD
Vecuronium—Face oedema—Epirubicin—sarcoma	0.00177	0.0074	CcSEcCtD
Vecuronium—ABCB1—hematopoietic system—sarcoma	0.00176	0.0108	CbGeAlD
Vecuronium—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00176	0.00733	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00167	0.00696	CcSEcCtD
Vecuronium—Hypersensitivity—Thiotepa—sarcoma	0.00165	0.00689	CcSEcCtD
Vecuronium—Face oedema—Doxorubicin—sarcoma	0.00164	0.00685	CcSEcCtD
Vecuronium—Hypersensitivity—Dactinomycin—sarcoma	0.00164	0.00684	CcSEcCtD
Vecuronium—Muscular weakness—Epirubicin—sarcoma	0.00162	0.00676	CcSEcCtD
Vecuronium—Anaphylactic shock—Etoposide—sarcoma	0.00161	0.00672	CcSEcCtD
Vecuronium—Tachycardia—Etoposide—sarcoma	0.00157	0.00656	CcSEcCtD
Vecuronium—Skin disorder—Etoposide—sarcoma	0.00156	0.00653	CcSEcCtD
Vecuronium—Urticaria—Mitoxantrone—sarcoma	0.00154	0.00642	CcSEcCtD
Vecuronium—Hypotension—Etoposide—sarcoma	0.0015	0.00628	CcSEcCtD
Vecuronium—Muscular weakness—Doxorubicin—sarcoma	0.0015	0.00626	CcSEcCtD
Vecuronium—Hypersensitivity—Vincristine—sarcoma	0.00146	0.00611	CcSEcCtD
Vecuronium—Hypersensitivity—Mitoxantrone—sarcoma	0.00143	0.00595	CcSEcCtD
Vecuronium—Rash—Thiotepa—sarcoma	0.00141	0.0059	CcSEcCtD
Vecuronium—Dermatitis—Thiotepa—sarcoma	0.00141	0.00589	CcSEcCtD
Vecuronium—Rash—Dactinomycin—sarcoma	0.0014	0.00586	CcSEcCtD
Vecuronium—ABCB1—uterus—sarcoma	0.00133	0.00815	CbGeAlD
Vecuronium—Urticaria—Etoposide—sarcoma	0.00128	0.00534	CcSEcCtD
Vecuronium—Rash—Vincristine—sarcoma	0.00125	0.00523	CcSEcCtD
Vecuronium—Dermatitis—Vincristine—sarcoma	0.00125	0.00523	CcSEcCtD
Vecuronium—Connective tissue disorder—Epirubicin—sarcoma	0.00125	0.00521	CcSEcCtD
Vecuronium—ABCB1—lymphoid tissue—sarcoma	0.00124	0.0076	CbGeAlD
Vecuronium—Rash—Mitoxantrone—sarcoma	0.00122	0.0051	CcSEcCtD
Vecuronium—Dermatitis—Mitoxantrone—sarcoma	0.00122	0.00509	CcSEcCtD
Vecuronium—Hypersensitivity—Etoposide—sarcoma	0.00119	0.00495	CcSEcCtD
Vecuronium—Flushing—Epirubicin—sarcoma	0.00118	0.00492	CcSEcCtD
Vecuronium—Cardiac disorder—Epirubicin—sarcoma	0.00118	0.00492	CcSEcCtD
Vecuronium—Connective tissue disorder—Doxorubicin—sarcoma	0.00116	0.00482	CcSEcCtD
Vecuronium—Angiopathy—Epirubicin—sarcoma	0.00115	0.00481	CcSEcCtD
Vecuronium—Immune system disorder—Epirubicin—sarcoma	0.00115	0.00479	CcSEcCtD
Vecuronium—Mediastinal disorder—Epirubicin—sarcoma	0.00115	0.00478	CcSEcCtD
Vecuronium—ABCB1—bone marrow—sarcoma	0.00113	0.00692	CbGeAlD
Vecuronium—Erythema—Epirubicin—sarcoma	0.00111	0.00462	CcSEcCtD
Vecuronium—Flushing—Doxorubicin—sarcoma	0.00109	0.00455	CcSEcCtD
Vecuronium—Cardiac disorder—Doxorubicin—sarcoma	0.00109	0.00455	CcSEcCtD
Vecuronium—Angiopathy—Doxorubicin—sarcoma	0.00107	0.00445	CcSEcCtD
Vecuronium—Immune system disorder—Doxorubicin—sarcoma	0.00106	0.00443	CcSEcCtD
Vecuronium—Mediastinal disorder—Doxorubicin—sarcoma	0.00106	0.00442	CcSEcCtD
Vecuronium—Erythema—Doxorubicin—sarcoma	0.00102	0.00427	CcSEcCtD
Vecuronium—Rash—Etoposide—sarcoma	0.00102	0.00424	CcSEcCtD
Vecuronium—Dermatitis—Etoposide—sarcoma	0.00101	0.00423	CcSEcCtD
Vecuronium—ABCB1—testis—sarcoma	0.000966	0.00591	CbGeAlD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000935	0.0039	CcSEcCtD
Vecuronium—ABCB1—liver—sarcoma	0.000914	0.00559	CbGeAlD
Vecuronium—Anaphylactic shock—Epirubicin—sarcoma	0.000903	0.00377	CcSEcCtD
Vecuronium—Shock—Epirubicin—sarcoma	0.000888	0.00371	CcSEcCtD
Vecuronium—Nervous system disorder—Epirubicin—sarcoma	0.000885	0.0037	CcSEcCtD
Vecuronium—Tachycardia—Epirubicin—sarcoma	0.000881	0.00368	CcSEcCtD
Vecuronium—Skin disorder—Epirubicin—sarcoma	0.000877	0.00366	CcSEcCtD
Vecuronium—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000865	0.00361	CcSEcCtD
Vecuronium—Hypotension—Epirubicin—sarcoma	0.000844	0.00352	CcSEcCtD
Vecuronium—Anaphylactic shock—Doxorubicin—sarcoma	0.000835	0.00349	CcSEcCtD
Vecuronium—Shock—Doxorubicin—sarcoma	0.000822	0.00343	CcSEcCtD
Vecuronium—Nervous system disorder—Doxorubicin—sarcoma	0.000819	0.00342	CcSEcCtD
Vecuronium—Tachycardia—Doxorubicin—sarcoma	0.000815	0.0034	CcSEcCtD
Vecuronium—Skin disorder—Doxorubicin—sarcoma	0.000811	0.00339	CcSEcCtD
Vecuronium—Hypotension—Doxorubicin—sarcoma	0.00078	0.00326	CcSEcCtD
Vecuronium—Urticaria—Epirubicin—sarcoma	0.000717	0.00299	CcSEcCtD
Vecuronium—ABCB1—lymph node—sarcoma	0.000701	0.00429	CbGeAlD
Vecuronium—Hypersensitivity—Epirubicin—sarcoma	0.000665	0.00278	CcSEcCtD
Vecuronium—Urticaria—Doxorubicin—sarcoma	0.000664	0.00277	CcSEcCtD
Vecuronium—Hypersensitivity—Doxorubicin—sarcoma	0.000615	0.00257	CcSEcCtD
Vecuronium—Rash—Epirubicin—sarcoma	0.000569	0.00238	CcSEcCtD
Vecuronium—Dermatitis—Epirubicin—sarcoma	0.000569	0.00237	CcSEcCtD
Vecuronium—Rash—Doxorubicin—sarcoma	0.000527	0.0022	CcSEcCtD
Vecuronium—Dermatitis—Doxorubicin—sarcoma	0.000526	0.0022	CcSEcCtD
